Pressure BioSciences, Inc. Announces Global Co-Marketing/Selling and Instrument Co-Development Agreement With Digilab

SOUTH EASTON, Mass., Jan. 11, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI") and Digilab, Inc. ("Digilab") (together "the companies") today announced that they have entered into a co-marketing/selling and research and development agreement. The companies intend to co-market and sell their respective product lines worldwide, including in industry publications, at scientific meetings, on each company's website, through common collaborator studies, at key industry trade shows, and in visits to customer sites. PBI and Digilab also intend to explore ways to co-develop new instrumentation, accessories/modules for existing instrumentation, and consumables that combine the robotics and high throughput capabilities of Digilab products with the extraction, protein digestion, and other advantages of PBI's Pressure Cycling Technology ("PCT") Platform.